Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 26, 2019 09:00 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Schedules Conference Call to Provide Corporate and Operational Progress Updates

RALEIGH, N.C., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and...
February 25, 2019 09:30 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Announces Acceptance of Three Abstracts Focusing on the Molecular Biology and Pharmacology of Larazotide for the 2019 Digestive Disease Week Conference

RALEIGH, N.C., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and...
February 22, 2019 10:00 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Announces a New Chief Executive Officer and Chief Medical Officer

RALEIGH, N.C., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
February 21, 2019 05:43 ET | Source: Research and Markets

Histologic Healing in Crohn's Disease, 2018 - Focus on KOL Perspectives Featuring Gilead & Celgene

Dublin, Feb. 21, 2019 (GLOBE NEWSWIRE) -- The "KOL Perspectives: Histologic Healing in Crohn's disease" drug pipelines has been added to ResearchAndMarkets.com's offering. This KOL...
February 19, 2019 09:00 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Subsidiary Regentys Corporation Receives Approval of Japanese Patent for Extracellular Matrix Hydrogel (Regentys ECMH™)

MIRAMAR, FL, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to...
February 07, 2019 08:34 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Announces Presentation at BIO CEO & Investor Conference

RALEIGH, N.C., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT) a clinical stage biotechnology company focused on developing novel autoimmune and inflammation...
February 04, 2019 10:55 ET | Source: Kenneth Rainin Foundation

Kenneth Rainin Foundation Awards Over $2 Million For Collaborative IBD Research Projects

Oakland, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- The Kenneth Rainin Foundation announced that it has awarded over $2 million in grants through its Synergy Awards program. This program encourages...
January 31, 2019 08:30 ET | Source: Cytori Therapeutics Inc.

Cytori Cell Therapy™ Clinical Trial Results in Crohn’s Disease

SAN DIEGO, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) announces the publication of results from a pilot investigator-initiated clinical trial of Cytori Cell Therapy™...
January 30, 2019 15:00 ET | Source: ARTIS Ventures

Largest Study of Its Kind Uses AI to Identify Unmet Needs of Patients with Severe Chronic Conditions; Emotional Support Takes Top Spot

San Francisco, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Today, NEJM Catalyst published new research co-authored by healthcare executives from UCB, ARTIS Ventures and Quid, that analyzed more than 500,000...
January 25, 2019 08:55 ET | Source: Research and Markets

Global Crohn's Disease Dynamic Market Forecast to 2026: Sales will Increase to $13.8 Billion at a CAGR of 4.4%

Dublin, Jan. 25, 2019 (GLOBE NEWSWIRE) -- The "Crohn's Disease: Dynamic Market Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. 2016 sales for the...